 |
 |

Topical MechlorethamineCutaneous Changes in Patients With Mycosis Fungoides After Its Administration
Norman M. Price, MB, ChB
Arch Dermatol. 1977;113(10):1387-1389.
Abstract
Six patients with mycosis fungoides were treated with topical mechlorethamine hydrochloride for periods of two to four years. Clinical and histological studies for radiomimetic and radiodermatitis-like effects failed to demonstrate any abnormalities. The only observed changes were generalized hyperpigmentation of the skin and melanin-containing melanophages in the papillary dermis. We consider that the long-term use of topical mechlorethamine may be a safe form of therapy, but that a continuous indefinite follow-up of patients on this medication should be mandatory.
(Arch Dermatol 113:1387-1389, 1977)
Author Affiliations
From the Dermatology Service, Veterans Administration Hospital, Palo Alto, and the Department of Dermatology, Stanford University Medical Center, Calif.
Footnotes
Accepted for publication March 8, 1977.
Reprint requests to Dermatology Service (151D), Veterans Administration Hospital, 3801 Miranda Ave, Palo Alto, CA 94304 (Dr Price).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
A Prospective Study of Cutaneous Intolerance to Topical Mechlorethamine Therapy in Patients With Cutaneous T-Cell Lymphomas
Esteve et al.
Arch Dermatol 1999;135:1349-1353.
ABSTRACT
| FULL TEXT
Cutaneous T-Cell Lymphomas: A Review of the Recent Literature
Zackheim
Arch Dermatol 1981;117:295-304.
ABSTRACT
|